132 related articles for article (PubMed ID: 21577206)
1. A novel interplay between oncogenic PFTK1 protein kinase and tumor suppressor TAGLN2 in the control of liver cancer cell motility.
Leung WK; Ching AK; Chan AW; Poon TC; Mian H; Wong AS; To KF; Wong N
Oncogene; 2011 Nov; 30(44):4464-75. PubMed ID: 21577206
[TBL] [Abstract][Full Text] [Related]
2. Identification of PFTAIRE protein kinase 1, a novel cell division cycle-2 related gene, in the motile phenotype of hepatocellular carcinoma cells.
Pang EY; Bai AH; To KF; Sy SM; Wong NL; Lai PB; Squire JA; Wong N
Hepatology; 2007 Aug; 46(2):436-45. PubMed ID: 17559150
[TBL] [Abstract][Full Text] [Related]
3. PFTK1 interacts with cyclin Y to activate non-canonical Wnt signaling in hepatocellular carcinoma.
Sun T; Co NN; Wong N
Biochem Biophys Res Commun; 2014 Jun; 449(1):163-8. PubMed ID: 24824184
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of Caldesmon by PFTAIRE1 kinase promotes actin binding and formation of stress fibers.
Leung WK; Ching AK; Wong N
Mol Cell Biochem; 2011 Apr; 350(1-2):201-6. PubMed ID: 21184254
[TBL] [Abstract][Full Text] [Related]
5. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.
Ching YP; Leong VY; Lee MF; Xu HT; Jin DY; Ng IO
Cancer Res; 2007 Apr; 67(8):3601-8. PubMed ID: 17440071
[TBL] [Abstract][Full Text] [Related]
6. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
7. PFTK1 Promotes Gastric Cancer Progression by Regulating Proliferation, Migration and Invasion.
Yang L; Zhu J; Huang H; Yang Q; Cai J; Wang Q; Zhu J; Shao M; Xiao J; Cao J; Gu X; Zhang S; Wang Y
PLoS One; 2015; 10(10):e0140451. PubMed ID: 26488471
[TBL] [Abstract][Full Text] [Related]
8. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
[TBL] [Abstract][Full Text] [Related]
9. MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling.
Wong QW; Ching AK; Chan AW; Choy KW; To KF; Lai PB; Wong N
Clin Cancer Res; 2010 Feb; 16(3):867-75. PubMed ID: 20103675
[TBL] [Abstract][Full Text] [Related]
10. LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma.
Wang B; Feng P; Xiao Z; Ren EC
J Hepatol; 2009 Mar; 50(3):528-37. PubMed ID: 19155088
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma.
Chuma M; Sakamoto M; Yasuda J; Fujii G; Nakanishi K; Tsuchiya A; Ohta T; Asaka M; Hirohashi S
J Hepatol; 2004 Oct; 41(4):629-36. PubMed ID: 15464244
[TBL] [Abstract][Full Text] [Related]
12. p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells.
Ip CK; Cheung AN; Ngan HY; Wong AS
Oncogene; 2011 May; 30(21):2420-32. PubMed ID: 21258406
[TBL] [Abstract][Full Text] [Related]
13. [Malignant transformation and alteration of actin-related proteins].
Kakunaga T
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):1996-2001. PubMed ID: 3606134
[TBL] [Abstract][Full Text] [Related]
14. HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma.
Wu X; Jia HL; Wang YF; Ren N; Ye QH; Sun HC; Wang L; Liu YK; Tang ZY; Qin LX
Oncogene; 2006 Mar; 25(12):1832-40. PubMed ID: 16261160
[TBL] [Abstract][Full Text] [Related]
15. Cell motility mediated by rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma.
Genda T; Sakamoto M; Ichida T; Asakura H; Kojiro M; Narumiya S; Hirohashi S
Hepatology; 1999 Oct; 30(4):1027-36. PubMed ID: 10498656
[TBL] [Abstract][Full Text] [Related]
16. β-catenin plays a key role in metastasis of human hepatocellular carcinoma.
Lai TY; Su CC; Kuo WW; Yeh YL; Kuo WH; Tsai FJ; Tsai CH; Weng YJ; Huang CY; Chen LM
Oncol Rep; 2011 Aug; 26(2):415-22. PubMed ID: 21617877
[TBL] [Abstract][Full Text] [Related]
17. miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness.
Götte M; Mohr C; Koo CY; Stock C; Vaske AK; Viola M; Ibrahim SA; Peddibhotla S; Teng YH; Low JY; Ebnet K; Kiesel L; Yip GW
Oncogene; 2010 Dec; 29(50):6569-80. PubMed ID: 20818426
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of myopodin expression reduces invasion and motility of PC-3 prostate cancer cells.
De Ganck A; De Corte V; Bruyneel E; Bracke M; Vandekerckhove J; Gettemans J
Int J Oncol; 2009 May; 34(5):1403-9. PubMed ID: 19360353
[TBL] [Abstract][Full Text] [Related]
19. Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells.
Boissan M; De Wever O; Lizarraga F; Wendum D; Poincloux R; Chignard N; Desbois-Mouthon C; Dufour S; Nawrocki-Raby B; Birembaut P; Bracke M; Chavrier P; Gespach C; Lacombe ML
Cancer Res; 2010 Oct; 70(19):7710-22. PubMed ID: 20841469
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of cortactin and N-WASP-mediated actin polymerization by missing in metastasis (MIM) protein.
Lin J; Liu J; Wang Y; Zhu J; Zhou K; Smith N; Zhan X
Oncogene; 2005 Mar; 24(12):2059-66. PubMed ID: 15688017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]